Aktie A1XCMU ABATTIS BIOCEUTICALS CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Abattis Bioceuticals Corp.

Aktien

A1XCMU

CA00258G1037

ATTBF

Markt geschlossen - OTC Markets
Andere Börsenplätze
 15:30:05 26.06.2024 		% 5 Tage % 1. Jan.
0,000001 USD -.--% Intraday Chart für Abattis Bioceuticals Corp. -.--% -.--%
2018 Abattis Bioceuticals Corp. gibt Umsatzprognose für das vierte Quartal 2018 ab CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2019
Abattis Bioceuticals Corp. Announces Board Changes
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) cancelled the acquisition of NutriVida Corp.
Abattis Bioceuticals Corp. Reports Earnings Results for the Third Quarter Ended June 30, 2019
Abattis Bioceuticals Corp.'s Equity Buyback announced on August 7, 2018, has expired.
Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2018
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) cancelled the acquisition of Winston Resources Inc..
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) completed the acquisition of Pro Natura BV from The Catalyst Capital Group Inc.
Abattis Bioceuticals : Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates
Abattis Bioceuticals Corp. Announces Management Changes
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) agreed to acquire Pro Natura BV from The Catalyst Capital Group Inc. for €15.7 million.
Abattis Bioceuticals Corp. Announces Resignations in Board
British Columbia Securities Commission Removes Temporary Order on Abattis Bioceuticals Corp
Abattis Bioceuticals Corp Announces Launch of Its New Website and Provide an Operational Update
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) signed a letter of intent to acquire NutriVida Corp. for CAD 15 million.
Abattis Bioceuticals Corp Signs a Distribution Agreement with Shefield &Sons Tobacconists Inc. to Sell the Abattis Vaporizer Line in all Shefield &Sons Stores Across Canada
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) acquired Select Strains Inc. for $3.5 million.
Abattis Bioceuticals Corp. Announces Executive Changes
Abattis Intends To Seek Acquisitions
Abattis Bioceuticals Corp. Announces Board Changes
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1XCMU Aktie
  4. Nachrichten Abattis Bioceuticals Corp.
  5. Andere Sprachen